Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre‐operative diagnosis of pelvic masses
S Tingulstad, B Hagen, FE Skjeldestad… - … Journal of Obstetrics …, 1996 - Wiley Online Library
Objective To evaluate the ability of a risk of malignancy index (RMI), based on a serum
CA125 level, ultrasound findings and menopausal status, to discriminate a benign from a …
CA125 level, ultrasound findings and menopausal status, to discriminate a benign from a …
Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy
SL Opsjøn, NC Wathen, S Tingulstad… - American Journal of …, 1993 - Elsevier
Objective: Our purpose was to investigate the cytokines, tumor necrosis factor, interleukin-1,
and interleukin-6 in normal human pregnancy and labor. Study design: Bioassays were …
and interleukin-6 in normal human pregnancy and labor. Study design: Bioassays were …
Comparison of 'pattern recognition'and logistic regression models for discrimination between benign and malignant pelvic masses: a prospective cross validation
L Valentin, B Hagen, S Tingulstad… - Ultrasound in Obstetrics …, 2001 - Wiley Online Library
Objectives To test prospectively the diagnostic performance of two logistic regression
models for calculation of individual risk of malignancy in adnexal tumors (the 'Tailor …
models for calculation of individual risk of malignancy in adnexal tumors (the 'Tailor …
The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals
S Tingulstad, B Hagen, FE Skjeldestad… - Obstetrics & …, 1999 - journals.lww.com
Objective To assess the risk-of-malignancy index (a scoring system based on menopausal
status, ultrasound features, and serum CA 125) at district hospitals for referral of women with …
status, ultrasound features, and serum CA 125) at district hospitals for referral of women with …
Survival and prognostic factors in patients with ovarian cancer
S Tingulstad, FE Skjeldestad, TB Halvorsen… - Obstetrics & …, 2003 - Elsevier
OBJECTIVE: To assess incidence during a 10-year study period and to identify and discuss
clinical relevance for prognostic factors of survival within a cohort of Norwegian ovarian …
clinical relevance for prognostic factors of survival within a cohort of Norwegian ovarian …
[HTML][HTML] Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
…, IM Stefansson, J Marcickiewicz, S Tingulstad… - European journal of …, 2013 - Elsevier
Background Preoperative histologic examination of tumour tissue is essential when deciding
if endometrial cancer surgery should include lymph node sampling. We wanted to …
if endometrial cancer surgery should include lymph node sampling. We wanted to …
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer
…, IM Stefansson, J Marcickiewicz, S Tingulstad… - Clinical cancer …, 2011 - AACR
Purpose: Overexpression of the oncogen Stathmin has been linked to aggressive
endometrial carcinoma and a potential for PI3Kinase inhibitors in this disease. We wanted to …
endometrial carcinoma and a potential for PI3Kinase inhibitors in this disease. We wanted to …
The effect of centralization of primary surgery on survival in ovarian cancer patients
S Tingulstad, FE Skjeldestad, B Hagen - Obstetrics & Gynecology, 2003 - Elsevier
OBJECTIVE: To examine the effect of centralized surgery on overall survival in patients with
ovarian cancer and, in particular, patients with advanced disease (stage III/IV). METHODS …
ovarian cancer and, in particular, patients with advanced disease (stage III/IV). METHODS …
[HTML][HTML] Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer …
…, A Vinnytska, I Vergote, S Tingulstad… - European Journal of …, 2020 - Elsevier
Abstract Background SENTIX (ENGOT-CX2/CEEGOG-CX1) is an international, multicentre,
prospective observational trial evaluating sentinel lymph node (SLN) biopsy without pelvic …
prospective observational trial evaluating sentinel lymph node (SLN) biopsy without pelvic …
[HTML][HTML] The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas
G Aune, AK Stunes, S Tingulstad… - … journal of clinical and …, 2011 - ncbi.nlm.nih.gov
The identification of new proliferation markers could have clinical implications in ovarian
carcinoma by stratifying patients for treatment and follow-up. The aim of this study was to …
carcinoma by stratifying patients for treatment and follow-up. The aim of this study was to …